Skystar Bio-Pharmaceutical Co. (SKBI) Reports Q4 EPS of $0.13
Tweet
Share
E-mailGet Alerts SKBI Hot Sheet
Price: $0.00 --0%
Financial Fact:
General and administrative: 1.9M
Today's EPS Names:
OCCI, PMCB, BRID, More
Financial Fact:
General and administrative: 1.9M
Today's EPS Names:
OCCI, PMCB, BRID, More
Join SI Premium – FREE
Skystar Bio-Pharmaceutical Co. (NASDAQ: SKBI) reported Q4 EPS of $0.13, versus $0.09 reported last year. Revenue for the quarter came in at $6.83 million, versus $5.53 million reported last year.
For earnings history and earnings-related data on Skystar Bio-Pharmaceutical Co. (SKBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler sees Google TPU sales hitting $104BN by 2028
- AAR agrees to buy 65% stake in MRO Holdings for $4 billion
- PB Fintech Limited (POLICYBZ:IN) PT Lowered to INR1,425 at Investec
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
